Three priorities to urgently increase access to COVID-19 vaccines Innovative biopharmaceutical companies are at the forefront of the global effort to develop and manufacture safe and effective COVID-19 vaccines and treatments. Today, over 12 billion doses of vaccines have been produced, and more than 60 percent of the world’s population have received at least one…
A synergy that promotes the well-being of patients Well-being is related to how each person feels about himself/herself, his/her health, and his/her environment. Therefore, promoting the well-being of patients is one of the priorities shared by the pharmaceutical industry and partnerships. In this regard, on December 1, the Central American and Caribbean Federation of Pharmaceutical…
FIFARMA Participates in the AMEPRES 6th International Meeting on Health Regulation The 6th International Meeting on Health Regulation, organized by the Mexican Association of Health Regulatory Professionals (AMEPRES) took place between November 9th and 12th, 2021 in a virtual way. This is an event of great importance for the health regulation sector of medical products…
The basics of longevity in Latin America One issue that has ever crossed through our mind, has to do with that natural process in human beings, the product of the course of life, of the accumulation of years -and learnings-: Aging. The first Latin American Longevity Summit, organized by AMIIF, Jthereum Corporation and Funsalud, brought…
Learn more about HIV-AIDS with these five frequently asked questions HIV continues to be one of the world’s biggest public health problems. In 2020, 37.7 million people were living with HIV worldwide. However, increasing access to prevention, diagnosis, treatment and care has made HIV a treatable chronic health problem. People living with HIV are now…
The story of a virus: HIV and Aids Approximately 40 years have passed since the first cases of AIDS were discovered in the United States in 1981. At that time, very little was known about this virus, and the diagnosis was considered a death sentence because there were no treatments available, and the causes were…
Vaccines: Innovations that change history The pandemic generated by COVID-19 has shown us the importance of research for vaccine development. In this sense, pharmaceutical R&D industry is constantly working to generate responses to public health emergencies, researching and developing technologies for the future to have impact on people’s lives. It was in this context that…
Strengthening regulatory systems in the Americas region: lessons learned from National Regulatory Authorities Last October, FIFARMA and ALAFARPE held an internal workshop called “Strengthening of Regulatory Systems: Learnings and experience of the regulatory authorities in Latin America” with the purpose of understanding the regulatory landscape in the region. The activity was framed within the guidelines…
How does ethics impact the health sector? Ethics relates to the study of morality and human action. Ethics determines what is good, bad, obligatory, permitted, etc. in relation to actions or decisions. Thus, it has been established that ethical business practices ensure long – term sustainable growth for SMEs, especially in the medical technology and…
Innovative strategies to guarantee the coverage, timelines, and quality of health care in Colombia Experts and leaders of the health sector discussed learnings, opportunities and challenges regarding the implementation of innovative access models in the country. Bogotá, November 2021-. In a virtual event organized by the Association of Pharmaceutical Research and Development Laboratories – AFIDRO…
